ECSP10010321A - Bisfosfonatos de alquilo de 2 a 5 átomos de carbono-imidazol - Google Patents
Bisfosfonatos de alquilo de 2 a 5 átomos de carbono-imidazolInfo
- Publication number
- ECSP10010321A ECSP10010321A EC2010010321A ECSP10010321A ECSP10010321A EC SP10010321 A ECSP10010321 A EC SP10010321A EC 2010010321 A EC2010010321 A EC 2010010321A EC SP10010321 A ECSP10010321 A EC SP10010321A EC SP10010321 A ECSP10010321 A EC SP10010321A
- Authority
- EC
- Ecuador
- Prior art keywords
- diseases
- treatment
- compounds
- imidazol
- atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describen ácidos [(imidazol-1-il)-1-hidroxi-1-fosfono-etil]-fosfónicos sustituidos por alquilo de 2 a 5 átomos de carbono, así como métodos o procesos para su fabricación, su uso en la fabricación de formulaciones farmacéuticas, su uso en el tratamiento de enfermedades, métodos para utilizarlos en el tratamiento de enfermedades, formulaciones farmacéuticas que los abarcan, y/o los compuestos para utilizarse en el tratamiento de enfermedades. Los compuestos son capaces de inhibir la resorción ósea excesiva o inapropiada, y para el tratamiento de otras enfermedades que sean causadas por una prenilación excesiva de las proteínas objetivo, tales como síndrome de progeria de Hutchinson-Gilford. Los compuestos son de la Fórmula I, en donde uno de R1 y R2 es hidrógeno, y el otro es alquilo de 2 a 5 átomos de carbono que está ramificado o no ramificado, y que pueden estar en forma libre, o en la forma de un éster, y/o de una sal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07122016 | 2007-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP10010321A true ECSP10010321A (es) | 2010-08-31 |
Family
ID=39154111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2010010321A ECSP10010321A (es) | 2007-11-30 | 2010-06-30 | Bisfosfonatos de alquilo de 2 a 5 átomos de carbono-imidazol |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7977323B2 (es) |
| EP (1) | EP2225252B1 (es) |
| JP (1) | JP5244917B2 (es) |
| KR (1) | KR20100092035A (es) |
| CN (1) | CN101835787A (es) |
| AR (1) | AR069437A1 (es) |
| AU (1) | AU2008328797B2 (es) |
| BR (1) | BRPI0819902A2 (es) |
| CA (1) | CA2701516A1 (es) |
| CL (1) | CL2008003545A1 (es) |
| CO (1) | CO6280421A2 (es) |
| CR (1) | CR11362A (es) |
| EA (1) | EA201000860A1 (es) |
| EC (1) | ECSP10010321A (es) |
| ES (1) | ES2386851T3 (es) |
| IL (1) | IL204657A0 (es) |
| MA (1) | MA31895B1 (es) |
| MX (1) | MX2010005786A (es) |
| NZ (1) | NZ584219A (es) |
| PE (1) | PE20091038A1 (es) |
| TN (1) | TN2010000138A1 (es) |
| TW (1) | TW200932248A (es) |
| WO (1) | WO2009068567A1 (es) |
| ZA (1) | ZA201001992B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0910901A2 (pt) * | 2008-04-04 | 2015-09-29 | Novartis Ag | composição farmacêutica com bisfosfonato |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| KR101813728B1 (ko) | 2009-07-31 | 2017-12-29 | 그뤼넨탈 게엠베하 | 결정화 방법 및 생체이용률 |
| WO2011147038A1 (en) | 2010-05-28 | 2011-12-01 | The Royal Institution For The Advancement Of Learning/Mcgill University | Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof |
| US9290526B2 (en) | 2010-05-28 | 2016-03-22 | The Royal Institution For The Advancement Of Learning/Mcgill University | Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof |
| WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
| CN102659840B (zh) * | 2012-05-10 | 2013-08-14 | 苏州普瑞诺药物技术有限公司 | 咪唑双膦酸类化合物及其可药用盐及药物用途 |
| WO2017208070A1 (en) | 2016-05-31 | 2017-12-07 | Grünenthal GmbH | Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis |
| EP3698797A1 (en) | 2017-10-16 | 2020-08-26 | Tsinghua University | Mevalonic acid pathway inhibitor and pharmaceutical composition thereof |
| CN112980809B (zh) * | 2021-03-17 | 2023-04-11 | 云南中烟工业有限责任公司 | 一种烟草法尼基焦磷酸合酶基因及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2038692T4 (es) | 1986-11-21 | 2012-02-10 | Novartis Ag | Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos. |
| CZ282609B6 (cs) * | 1991-02-26 | 1997-08-13 | Norwich Eaton Pharmaceuticals, Inc. | Směs v jednotné dávkovací formě pro léčení osteoporozy |
| GB9324143D0 (en) | 1993-11-24 | 1994-01-12 | Schering Agrochemicals Ltd | Triazole phosphonate pesticides |
| GB0029018D0 (en) * | 2000-11-28 | 2001-01-10 | Strakan Group Plc | Dermatological formulations |
| GB0029111D0 (en) | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
| WO2008128056A1 (en) | 2004-10-08 | 2008-10-23 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps |
| WO2006039721A2 (en) | 2004-10-08 | 2006-04-13 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
| AU2007304205A1 (en) | 2006-10-05 | 2008-04-10 | Novartis Ag | Pharmaceutical compositions comprising bisphosphonates |
| JP2010522765A (ja) | 2007-03-28 | 2010-07-08 | アレイ バイオファーマ、インコーポレイテッド | 受容体チロシンキナーゼとしてのイミダゾ[1,2−a]ピリジン化合物 |
-
2008
- 2008-11-26 CA CA2701516A patent/CA2701516A1/en not_active Abandoned
- 2008-11-26 CN CN200880112351A patent/CN101835787A/zh active Pending
- 2008-11-26 BR BRPI0819902-7A patent/BRPI0819902A2/pt not_active IP Right Cessation
- 2008-11-26 AU AU2008328797A patent/AU2008328797B2/en not_active Ceased
- 2008-11-26 KR KR1020107014395A patent/KR20100092035A/ko not_active Ceased
- 2008-11-26 NZ NZ584219A patent/NZ584219A/en not_active IP Right Cessation
- 2008-11-26 MX MX2010005786A patent/MX2010005786A/es active IP Right Grant
- 2008-11-26 ES ES08854485T patent/ES2386851T3/es active Active
- 2008-11-26 WO PCT/EP2008/066245 patent/WO2009068567A1/en not_active Ceased
- 2008-11-26 US US12/323,696 patent/US7977323B2/en not_active Expired - Fee Related
- 2008-11-26 EA EA201000860A patent/EA201000860A1/ru unknown
- 2008-11-26 JP JP2010535369A patent/JP5244917B2/ja active Active
- 2008-11-26 EP EP08854485A patent/EP2225252B1/en active Active
- 2008-11-27 AR ARP080105163A patent/AR069437A1/es active IP Right Grant
- 2008-11-27 PE PE2008001990A patent/PE20091038A1/es not_active Application Discontinuation
- 2008-11-28 TW TW097146484A patent/TW200932248A/zh unknown
- 2008-11-28 CL CL2008003545A patent/CL2008003545A1/es unknown
-
2010
- 2010-03-19 ZA ZA2010/01992A patent/ZA201001992B/en unknown
- 2010-03-22 IL IL204657A patent/IL204657A0/en unknown
- 2010-03-26 TN TNP2010000138A patent/TN2010000138A1/fr unknown
- 2010-04-09 CR CR11362A patent/CR11362A/es unknown
- 2010-05-26 CO CO10063351A patent/CO6280421A2/es not_active Application Discontinuation
- 2010-05-31 MA MA32880A patent/MA31895B1/fr unknown
- 2010-06-30 EC EC2010010321A patent/ECSP10010321A/es unknown
-
2011
- 2011-05-26 US US13/116,671 patent/US20110224173A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008328797B2 (en) | 2011-11-03 |
| ES2386851T3 (es) | 2012-09-03 |
| EP2225252B1 (en) | 2012-06-27 |
| US7977323B2 (en) | 2011-07-12 |
| PE20091038A1 (es) | 2009-08-19 |
| NZ584219A (en) | 2012-03-30 |
| CL2008003545A1 (es) | 2009-06-05 |
| EA201000860A1 (ru) | 2010-12-30 |
| WO2009068567A1 (en) | 2009-06-04 |
| KR20100092035A (ko) | 2010-08-19 |
| AR069437A1 (es) | 2010-01-20 |
| JP5244917B2 (ja) | 2013-07-24 |
| US20110224173A1 (en) | 2011-09-15 |
| ZA201001992B (en) | 2010-12-29 |
| CO6280421A2 (es) | 2011-05-20 |
| CR11362A (es) | 2010-06-14 |
| MA31895B1 (fr) | 2010-12-01 |
| TN2010000138A1 (en) | 2011-09-26 |
| US20090143337A1 (en) | 2009-06-04 |
| MX2010005786A (es) | 2010-06-09 |
| EP2225252A1 (en) | 2010-09-08 |
| CN101835787A (zh) | 2010-09-15 |
| AU2008328797A1 (en) | 2009-06-04 |
| TW200932248A (en) | 2009-08-01 |
| IL204657A0 (en) | 2010-11-30 |
| BRPI0819902A2 (pt) | 2015-05-19 |
| JP2011504908A (ja) | 2011-02-17 |
| CA2701516A1 (en) | 2009-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6280421A2 (es) | Bifosfatos de alquilo de 2 a 5 atomos de carbonoimidazol | |
| CR10250A (es) | Derivados de amida y su aplicación para el tratamiento de enfermedades relacionadas con proteína-g | |
| UY28877A1 (es) | Compuestos de metil-aril o heteroaril-amida sustituida y composiciones | |
| MX377255B (es) | Lipidos y composiciones de lipidos para el suministro de agentes activos. | |
| BR112012030923B8 (pt) | Composto derivado de piperidinona como inibidor de mdm2 e composição farmacêutica compreendendo o mesmo | |
| BRPI0512690A (pt) | análogos de fosfonato de compostos inibidores de hiv | |
| CR20160127A (es) | Pesticidas de azoles bicíclicos sustituidos con heterociclos | |
| CO6450621A2 (es) | Sulfonamidas nematocidas | |
| UY29122A1 (es) | Serinamidas sustituidas por benzoilo | |
| BRPI0809770B8 (pt) | Composto e composição para controlar uma praga de invertebrados | |
| UA110924C2 (uk) | Мезоіонні пестициди | |
| ECSP066966A (es) | Compuestos de aril-o heteroarilamida ortosustituidos | |
| GT200800184A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes. | |
| NI201100081A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa - iv para el tratamiento o prevención de diabetes. | |
| CR11554A (es) | Pirrolo-Pirimidinas y Pirrolo-Piridinas | |
| CR20140301A (es) | Derivados de betulina | |
| AR091857A1 (es) | INHIBIDORES DE CISTATIONIN-g-LIASA (CSE) | |
| BR112016029476A2 (pt) | complexos de aminoácido mineral de agentes ativos | |
| MY149180A (en) | Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof | |
| AR105080A1 (es) | Compuestos inhibidores de la señalización de la vía de notch | |
| BR112015010941A2 (pt) | pró-fármacos de gemcitabina e suas utilizações | |
| PE20090880A1 (es) | Compuestos heterociclicos como inhibidores de fosfatidilinositol 3-cinasa | |
| CY1116168T1 (el) | Συγκρυσταλλοι και αλατα αναστολεων toy ccr3 | |
| CO6660462A2 (es) | Derivados de ácido 3-heteroaroilamino-propiónico sustituidos con oxígeno y su uso como productos farmacéuticos | |
| PH12012501805A1 (en) | Crystalline salts of a potent hcv inhibitor |